International team reveals first prognosticator of survival in aggressive cancer

This is somewhat the first step in identifying the gene pRb2/p130, which has very good possibilities to help determine the most beneficial course of chemotherapy and/or radiation treatments following surgery, something every doctor and patient could value, more personalized medicine research and development at work and hopefully bring this type of diagnosis process to the office of the physician in time. BD

Clinicians have long sought a prognostic test for the disease, which can be highly aggressive and unpredictable, making it difficult to determine the most beneficial course of chemotherapy and/or radiation treatments following surgery. A prognostic indicator will help doctors determine which patients have a higher risk of recurrence of the disease and who might benefit from a more aggressive adjuvant therapy.